|
注册号: Registration number: |
ChiCTR2500104738 |
|
最近更新日期: Date of Last Refreshed on: |
2025-06-23 10:13:49 |
|
注册时间: Date of Registration: |
2025-06-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
膈肌、肋间肌纵向应变预测呼吸衰竭患者气管插管的价值 |
|
Public title: |
The value of longitudinal strain of diaphragm and intercostal muscles in predicting tracheal intubation in patients with respiratory failure |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
膈肌、肋间肌纵向应变预测呼吸衰竭患者气管插管的价值 |
|
Scientific title: |
The value of longitudinal strain of diaphragm and intercostal muscles in predicting tracheal intubation in patients with respiratory failure |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张慧娟 |
研究负责人: |
张慧娟 |
|
Applicant: |
Huijuan Zhang |
Study leader: |
Huijuan Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 157 5536 4383 |
研究负责人电话:
Study leader's |
+86 157 5536 4383 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhjuan0711@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhjuan0711@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国安徽省芜湖市镜湖区赭山西路2号皖南医学院弋矶山医院重症医学科 |
研究负责人通讯地址: |
中国安徽省芜湖市镜湖区赭山西路2号皖南医学院弋矶山医院重症医学科 |
|
Applicant address: |
Department of Intensive Care Medicine, Yijishan Hospital of Wannan Medical College, No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province, China |
Study leader's address: |
Department of Intensive Care Medicine, Yijishan Hospital of Wannan Medical College, No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
皖南医学院弋矶山医院 |
||
|
Applicant's institution: |
Yijishan Hospital of Wannan Medical College |
||
|
研究负责人所在单位: |
皖南医学院弋矶山医院 |
||
|
Affiliation of the Leader: |
Yijishan Hospital of Wannan Medical College |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2025)伦审研第(83)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
皖南医学院弋矶山医院科研与新技术伦理委员会 |
||
|
Name of the ethic committee: |
Scientific Research and New Technology of Wannan Medical College Yijishan Hospital IRB |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-05-13 00:00:00 | ||
|
伦理委员会联系人: |
吴佩 |
||
|
Contact Name of the ethic committee: |
Pei Wu |
||
|
伦理委员会联系地址: |
中国安徽省芜湖市镜湖区赭山西路2号皖南医学院弋矶山医院 |
||
|
Contact Address of the ethic committee: |
Yijishan Hospital of Wannan Medical College, No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 553 573 9209 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
皖南医学院弋矶山医院重症医学科 |
||||||||||||||||||||||
|
Primary sponsor: |
Department of Critical Care Medicine, Yijishan Hospital of Wannan Medical College |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国安徽省芜湖市镜湖区赭山西路2号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.2 Zheshan West Road, Jinghu District, Wuhu City, Anhui Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
安徽省危重症呼吸临床医学研究中心校级开放课题 |
||||||||||||||||||||||
|
Source(s) of funding: |
The School-level Open Project of the Critical Care Respiratory Clinical Medical Research Center of Anhui Province |
||||||||||||||||||||||
|
研究疾病: |
呼吸衰竭 |
||||||||||||||||||||||
|
Target disease: |
Respiratory failure |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
1.通过床旁超声扫查测量I型呼吸衰竭患者入组后不同时间点(入组1-2h,入组6h,入组12h)的肋间肌厚度,膈肌位移及增厚分数,随访记录入组患者气管插管结局事件。评估超声相关特征参数与I型呼吸衰竭患者气管插管等结局事件的相关性,以明确该类超声技术预测I型呼吸衰竭患者气管插管的价值。 2.拟构建床旁超声预测I型呼吸衰竭患者气管插管的模型,为临床呼吸危重症患者的个体化精准治疗提供依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. Intercostal muscle thickness, diaphragmatic displacement and thickening fraction were measured by bedside ultrasound at different time points (1-2h, 6h, 12h) after enrollment in patients with type I respiratory failure, and tracheal intubation outcome events were recorded during follow-up. To evaluate the correlation between ultrasound-related characteristic parameters and outcome events such as tracheal intubation in patients with type I respiratory failure, so as to clarify the value of this kind of ultrasound technology in predicting tracheal intubation in patients with type I respiratory failure. 2. To construct a model of bedside ultrasound for predicting tracheal intubation in patients with type I respiratory failure, so as to provide a basis for individualized precise treatment of clinical respiratory critical patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
(1)神经肌肉疾病史、慢性肺部疾病(如中度至重度限制性或阻塞性肺部疾病)和心脏或胸腔手术患者 (2)紧急气管插管的低氧血症患者 (3)合并II型呼吸衰竭 (4)入科前已经接受高流量或者无创呼吸机辅助治疗的患者。存在严重心脏疾病(如严重的心力衰竭、主动脉瓣狭窄等)者 (5)超声图片质量不佳,无法获取主要数据 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Patients with a history of neuromuscular disease, chronic pulmonary disease (e.g., moderate-to-severe restrictive or obstructive pulmonary disease), and cardiac or thoracic surgery; 2. Hypoxemia patients with emergency tracheal intubation; 3. Complicated with type II respiratory failure; 4. Patients who had received high-flow or non-invasive ventilation before admission. Patients with severe heart disease (such as severe heart failure, aortic valve stenosis, etc); 5. The quality of ultrasound images was poor, and the main data could not be obtained. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-13 00:00:00至 To 2026-06-13 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-06-30 00:00:00 至 To 2026-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
由于涉及患者敏感临床信息,暂不共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Due to the involvement of sensitive clinical information of patients, the original data are not shared for the time being |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |